Trium Capital LLP Chimerix Inc Transaction History
Trium Capital LLP
- $801 Million
- Q1 2025
A detailed history of Trium Capital LLP transactions in Chimerix Inc stock. As of the latest transaction made, Trium Capital LLP holds 544,153 shares of CMRX stock, worth $4.65 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
544,153Holding current value
$4.65 Million% of portfolio
0.58%Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
76Shares Held
40.5MCall Options Held
243KPut Options Held
110K-
Ra Capital Management, L.P. Boston, MA8.8MShares$75.2 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.04MShares$34.5 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.77MShares$32.2 Million0.32% of portfolio
-
Monaco Asset Management Sam2.82MShares$24.1 Million1.45% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.56MShares$21.8 Million0.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $748M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...